Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

Systemic lupus erythematosus.

Rahman A, Isenberg DA.

N Engl J Med. 2008 Feb 28;358(9):929-39. doi: 10.1056/NEJMra071297. Review. No abstract available.

PMID:
18305268
2.

[Molecular targets and their regulation in systemic lupus erythematosus and lupus nephritis].

Takasaki Y.

Nihon Jinzo Gakkai Shi. 2012;54(5):598-602. Review. Japanese. No abstract available.

PMID:
22991839
3.

New therapies for systemic lupus erythematosus: cellular targets.

Looney RJ, Anolik J, Sanz I.

Rheum Dis Clin North Am. 2006 Feb;32(1):201-15, xi. Review.

PMID:
16504831
4.

Rituximab anti-B-cell therapy in systemic lupus erythematosus: pointing to the future.

Sfikakis PP, Boletis JN, Tsokos GC.

Curr Opin Rheumatol. 2005 Sep;17(5):550-7. Review.

PMID:
16093832
5.

Mimicking self-antigens with synthetic peptides in systemic autoimmune rheumatic diseases.

Cai C, La Cava A.

Curr Clin Pharmacol. 2009 May;4(2):142-7. Review.

PMID:
19442079
6.

B-cell and T-cell function in systemic lupus erythematosus.

Via CS, Handwerger BS.

Curr Opin Rheumatol. 1993 Sep;5(5):570-4. Review.

PMID:
7691138
7.

B cells in SLE: different biological drugs for different pathogenic mechanisms.

Diamanti AP, Rosado MM, Carsetti R, Valesini G.

Autoimmun Rev. 2007 Dec;7(2):143-8. Epub 2007 Mar 22. Review.

PMID:
18035325
8.

Antibody-based therapies in systemic lupus erythematosus.

Iikuni N, La Cava A.

Mini Rev Med Chem. 2009 Jun;9(7):829-46. Review.

PMID:
19519508
9.

Systemic lupus erythematosus in children: current and emerging therapies.

Macdermott EJ, Adams A, Lehman TJ.

Lupus. 2007;16(8):677-83. Review.

PMID:
17711907
10.

Mechanisms of physiologic B cell responses and B cell hyperactivity in systemic lupus erythematosus.

Zubler RH, Huang YP, Miescher PA.

Springer Semin Immunopathol. 1986;9(2-3):195-218. Review. No abstract available.

PMID:
2949381
11.

Systemic lupus erythematosus conundrums.

Wardle EN.

Saudi J Kidney Dis Transpl. 2009 Sep;20(5):731-6. Review.

12.

Anti-CD20 monoclonal antibody in rheumatoid arthritis and systemic lupus erythematosus.

Goldblatt F, Isenberg DA.

Handb Exp Pharmacol. 2008;(181):163-81. Review.

PMID:
18071946
13.

Recent advances in systemic lupus erythematosus.

Klinman DM.

Curr Opin Immunol. 1989 Apr;1(4):740-6. Review. No abstract available.

PMID:
2679728
14.

Do cytokines play a role in systemic lupus erythematosus?

Singh AK.

J R Coll Physicians Lond. 1992 Oct;26(4):374-6. Review.

PMID:
1432876
15.

Rituximab use in systemic lupus erythematosus pneumonitis and a review of current reports.

Lim SW, Gillis D, Smith W, Hissaria P, Greville H, Peh CA.

Intern Med J. 2006 Apr;36(4):260-2. Review.

PMID:
16640745
16.

Lymphocytes, cytokines, inflammation, and immune trafficking.

Tsokos GC.

Curr Opin Rheumatol. 1995 Sep;7(5):376-83. Review.

PMID:
8519609
17.

Origin and significance of autoantibodies.

Dighiero G, Kaushik A, Poncet P, Ge XR.

Concepts Immunopathol. 1987;4:42-76. Review. No abstract available.

PMID:
3297339
18.

B-cell depletion and repopulation in autoimmune diseases.

Pers JO, Daridon C, Bendaoud B, Devauchelle V, Berthou C, Saraux A, Youinou P.

Clin Rev Allergy Immunol. 2008 Feb;34(1):50-5. doi: 10.1007/s12016-007-8015-4. Review.

PMID:
18270858
19.

[Role of T lymphocytes in systemic lupus erythematosus].

Zubler RH, Miescher PA.

Ann Med Interne (Paris). 1990;141(3):208-12. Review. French.

PMID:
2195945
20.

The role of anti-DNA idiotype antibodies in systemic lupus erythematosus.

Mozes E, Mendlovic S.

Crit Rev Immunol. 1990;10(4):329-45. Review. No abstract available.

PMID:
2285460

Supplemental Content

Support Center